In a 56‑year‑old diabetic woman with fever, leukocytosis, severe thrombocytopenia, anemia and ferritin >2000 µg/L, does a normal fibrinogen level of 400 mg/dL and triglyceride level of 170 mg/dL exclude hemophagocytic lymphohistiocytosis (HLH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Fibrinogen and Triglycerides Do NOT Exclude HLH

A fibrinogen of 400 mg/dL and triglycerides of 170 mg/dL do not exclude hemophagocytic lymphohistiocytosis (HLH) in this patient, and you should proceed urgently with further diagnostic workup and strongly consider initiating HLH-directed therapy given the constellation of fever, severe thrombocytopenia, anemia, leukocytosis, and markedly elevated ferritin >2000 µg/L. 1

Why These "Normal" Values Don't Rule Out HLH

The HLH-2004 diagnostic criteria require 5 of 8 criteria to be met, and the hypertriglyceridemia/hypofibrinogenemia criterion is satisfied if either triglycerides ≥265 mg/dL or fibrinogen ≤1.5 g/L (150 mg/dL) is present. 1 Your patient's values (triglycerides 170 mg/dL, fibrinogen 400 mg/dL) do not meet this specific criterion, but this is only one of eight possible criteria. 1

Critical point: HLH can be diagnosed and treatment initiated even when fewer than 5 criteria are fulfilled if clinical suspicion is sufficiently high. 1 The guidelines explicitly state that "HLH may be strongly considered, and HLH-directed therapy may be initiated, even though 5 criteria are not fulfilled." 1

Your Patient Likely Already Meets Multiple HLH Criteria

Let's count what you have:

  1. Fever – present 1
  2. Cytopenias affecting ≥2 lineages – severe thrombocytopenia (platelets <100 × 10⁹/L) and anemia (hemoglobin <90 g/L) = 2 criteria met 1
  3. Ferritin ≥500 mg/L – your patient has >2000 µg/L = criterion met 1, 2

You already have at least 4 criteria, and potentially 5 if leukocytosis represents neutrophilia masking underlying lymphopenia or if splenomegaly is present on imaging. 1

Essential Next Steps

Immediately Obtain These Tests:

  • Soluble CD25 (sCD25/soluble IL-2 receptor) – this is the single best diagnostic test for adult HLH with AUC 0.90 versus ferritin's 0.78; a level ≥2400 U/mL meets diagnostic criteria 2
  • NK cell activity – low or absent activity is a diagnostic criterion 1, 2
  • Bone marrow aspirate – look for hemophagocytosis, though its absence does NOT exclude HLH; serial aspirates or examination of other tissues (liver, lymph nodes, spleen) may be needed 1, 3
  • Imaging – assess for splenomegaly and hepatomegaly 1

Search for Underlying Triggers:

In a 56-year-old diabetic woman, you must aggressively pursue: 1

  • Malignancy screening (especially T-cell/NK-cell lymphomas, B-cell lymphomas) – malignancy-associated HLH occurs in up to 68% of adults and is the leading cause in this age group 1, 2
  • Viral infections – EBV, CMV, other herpes viruses 4, 5
  • Autoimmune triggers – macrophage activation syndrome in rheumatic diseases 5

Important Caveats About Fibrinogen and Triglycerides in HLH

Fibrinogen can be falsely "normal" or even elevated in HLH because it is an acute-phase reactant. 4, 5 In the setting of severe inflammation, fibrinogen may rise despite ongoing consumption, masking the expected hypofibrinogenemia. A level of 400 mg/dL in a critically ill patient with suspected HLH should be interpreted cautiously—it may actually represent relative hypofibrinogenemia for the degree of inflammation present. 4

Triglycerides at 170 mg/dL are below the HLH threshold (≥265 mg/dL), but lipid abnormalities can evolve over time and may not be present at initial presentation. 1, 5 Serial measurements are warranted. 1

Case reports document HLH with normal ferritin, triglycerides, or fibrinogen, particularly in atypical presentations or early disease. 6 One pediatric case series showed that even familial HLH can present with normal ferritin. 6

Treatment Should Not Be Delayed

Do not wait for all diagnostic criteria to be met before initiating therapy. 1, 2 HLH is a life-threatening hyperinflammatory syndrome with 50% mortality across all etiologies. 4 The HLH-2004 treatment protocol (dexamethasone, etoposide, cyclosporine A) should be started urgently when clinical suspicion is high, even if only 4 criteria are met. 1, 7

Multidisciplinary involvement including intensive care is essential given the risk of multi-organ failure. 4

Alternative Diagnostic Tool: HScore

Consider calculating the HScore, which was developed specifically for adults with suspected secondary HLH and may be more applicable than pediatric-derived HLH-2004 criteria. 1, 3 The HScore incorporates:

  • Known immunosuppression (diabetes may contribute) 1
  • Temperature 1
  • Organomegaly 1
  • Number of cytopenias (your patient has ≥2) 1
  • Ferritin level (>2000 scores points) 1
  • Triglyceride and fibrinogen levels 1
  • AST elevation 1
  • Hemophagocytosis on bone marrow 1

A high HScore (typically >169) supports HLH diagnosis even when classic criteria are not fully met. 1, 3

Bottom Line

Your patient's clinical picture—fever, severe cytopenias, markedly elevated ferritin >2000 µg/L in a diabetic woman—is highly concerning for HLH regardless of normal fibrinogen and triglycerides. 1, 2 Proceed immediately with sCD25, NK cell activity, bone marrow examination, and malignancy/infection workup while preparing to initiate HLH-directed therapy. 1, 2 Delay in treatment significantly worsens mortality. 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Soluble CD25 (sCD25) in the Diagnosis and Management of Adult Hemophagocytic Lymphohistiocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Hemophagocytic lymphohistiocytosis].

La Revue de medecine interne, 2013

Research

Hemophagocytic syndromes.

Blood reviews, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.